Results 11 to 20 of about 747,376 (295)
Ca-A Cancer Journal for Clinicians, 1986 At present, adjuvant chemotherapy exerts no significant impact on long-term survival and only occasionally provides brief palliation in head and neck cancer. The major contribution of chemotherapy has been in the preoperative period, when therapy for advanced squamous cell carcinoma may render some patients candidates for curative operations or ...
C K Osborne
exaly +5 more sources
Therapeutics and Clinical Risk Management, 2015 Katsuhiko Shimizu, Riki Okita, Shinsuke Saisho, Takuro Yukawa, Ai Maeda, Yuji Nojima, Masao Nakata Department of General Thoracic Surgery, Kawasaki Medical School, Kurashiki, Japan Background: Adjuvant chemotherapy after the complete resection of non ...
Shimizu K +6 more
doaj +1 more source
Real-World Application of a Machine Learning-Based Early Recurrence Model for Guiding Adjuvant Chemotherapy Use in Patients with Gallbladder Cancer [PDF]
Gut and LiverBackground/Aims : Although recent randomized controlled trials have reported the efficacy of adjuvant chemotherapy for resected biliary tract cancer, discrepancies remain between recommendations and real-world practice.
Won-Gun Yun +7 more
doaj +2 more sources
Chemotherapy adjuvant and chemotherapy-induced neutropenia
Taiwanese Journal of Obstetrics & Gynecology, 2022 Yiu-Tai Li, Szu-Ting Yang, Peng-Hui Wang
doaj +3 more sources
Thoracic Surgery Clinics, 2020 Five-year survival rates for patients with early-stage non-small cell lung cancer have room for improvement. Adjuvant chemotherapy results in a small but significant increase in overall survival at 5 years. Efforts to improve outcomes by intensifying adjuvant treatment, utilizing cancer-specific vaccines or tyrosine kinase inhibitors in unselected ...
Jessica A, Hellyer, Heather A, Wakelee
+5 more sources
Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims Adjuvant chemotherapy is the standard of care for resected stage II–IIIA non-small cell lung cancer (NCSLC). The efficacy of adjuvant chemotherapy in stage IB (< 4 cm) NSCLC with high-risk factors is controversial.
Juwhan Choi +12 more
doaj +1 more source
Novel molecular classification of endometrial cancer - current and future clinical implications [PDF]
Vojnosanitetski Pregled, 2023 nema
Mandić Aljoša +4 more
doaj +1 more source
Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse [PDF]
Tuberculosis and Respiratory Diseases, 2023 A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the early and resectable stage. Despite the use of platinum-based adjuvant chemotherapy, there was only a marginal increase in overall survival and a 15 ...
Jeong Uk Lim
doaj +1 more source
Annals of Gastroenterological Surgery, 2023 Aim We aimed to clarify the use of adjuvant chemotherapy and the prognosis of elderly colorectal cancer patients compared with non‐elderly patients, and the usefulness of sarcopenia as an indicator for the introduction and completion of adjuvant ...
Takuya Shiraishi +8 more
doaj +1 more source
Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy. [PDF]
PLoS ONE, 2013 BACKGROUND: A phase III clinical trial has already shown the survival benefits of postoperative chemotherapy in gastric cancer. However, there are limited published data concerning the elderly.
Ying Jin +10 more
doaj +1 more source